• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24040 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     HAYES, Inc. Telerehabilitation for musculoskeletal conditions, neuromuscular conditions, and mobility impairment
1997     Danish Institute for Health Services Research (DSI) Telescopic surgery in the abdomen. Consensus report
2012     Adelaide Health Technology Assessment (AHTA) Television marketing of unhealthy food and beverages to children in Australia: a review of published evidence from 2009
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Telithromycin
2007     NIHR Horizon Scanning Centre (NIHR HSC) Temozolomide (Temodal) for advanced metastatic melanoma: horizon scanning technology briefing
2017     Agency for Care Effectiveness (ACE) Temozolomide for the treatment of malignant glioma
2024     National Institute for Health and Care Excellence (NICE) Temperature control to improve neurological outcomes after cardiac arrest. NICE interventional procedures guidance 782
2006     VA Technology Assessment Program (VATAP) Temporal artery thermometry in the post-operative setting
2018     NIHR Health Technology Assessment programme Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
2024     NIHR Health Technology Assessment programme Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
2024     NIHR Health and Social Care Delivery Program Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
2006     HAYES, Inc. Temporomandibular joint (TMJ) reconstruction with the patient-fitted TMJ reconstruction prosthesis (TMJ Concepts)
2005     Adelaide Health Technology Assessment (AHTA) Temptouch (R): infrared thermometer device for prevention of foot ulcers in people with diabetes
2006     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus (Torisel) for advanced or metastatic renal cell carcinoma: horizon scanning technology briefing
2008     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus (Torisel) for mantle cell lymphoma - relapsed and/or refractory
2005     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus for locally advanced and metastatic breast cancer - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus for metastatic renal cell carcinoma (stage IV) - horizon scanning review
2010     National Institute for Health and Care Excellence (NICE) Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal). NICE technology appraisal guidance 207
2024     National Institute for Health and Care Excellence (NICE) Tenecteplase for treating acute ischaemic stroke. NICE technology appraisal guidance 990
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction
2017     National Institute for Health and Care Excellence (NICE) Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal). NICE technology appraisal guidance 435
2021     Agency for Care Effectiveness (ACE) Tenofovir alafenamide for treating chronic hepatitis B infection
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir alafenamide monotherapy for hepatitis B
2009     National Institute for Health and Care Excellence (NICE) Tenofovir disoproxil for the treatment of chronic hepatitis B. NICE technology appraisal guidance 173
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®) for the treatment of hepatitis B
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir disoproxil fumarate for hepatitis B: horizon scanning technology briefing
2010     NIHR Health Technology Assessment programme Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
2009     National Institute for Health and Care Excellence (NICE) Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions). NICE interventional procedures guidance 299
2000     NIHR Horizon Scanning Centre (NIHR HSC) Tension free vaginal tape for urinary incontinence - horizon scanning review
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tension-free vaginal tape (TVT) for urinary incontinence
2008     Haute Autorite de sante (HAS) Tension-free vaginal tape and women stress incontinence
2004     Medical Advisory Secretariat (MAS) Tension-free vaginal tape for stress urinary incontinence
2005     HAYES, Inc. Tension-free vaginal tape procedure for treatment of female stress urinary incontinence
2002     HAYES, Inc. Tension-free vaginal tape procedure for treatment of female stress urinary incontinence
2022     National Institute for Health and Care Excellence (NICE) Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterations. NICE technology appraisal guidance 789
2014     NIHR Horizon Scanning Centre (NIHR HSC) Terahertz intraoperative breast cancer probe
2011     Agency for Healthcare Research and Quality (AHRQ) Terbutaline pump for the prevention of preterm birth
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Teriflunomide (Aubagio — Genzyme Canada) indication: relapsing-remitting multiple sclerosis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Teriflunomide for relapsing multiple sclerosis (MS) - first line
2013     NIHR Health Technology Assessment programme Teriflunomide for treating relapsing forms of multiple sclerosis
2014     National Institute for Health and Care Excellence (NICE) Teriflunomide for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 303
2004     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Teriparatide
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Teriparatide (Forsteo®) for the treatment of osteoporosis in men at increased risk of fracture
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Teriparatide and bisphosphonates for treatment of osteoporosis in women: a clinical and economic analysis
2001     NIHR Horizon Scanning Centre (NIHR HSC) Teriparatide for osteoporosis - horizon scanning review
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Teriparatide for the treatment of osteoporosis
2017     The Regional Health Technology Assessment Centre (HTA-centrum) Term breech presentation - caesarean section versus vaginal delivery
2001     Israel Center for Technology Assessment in Health Care (ICTAHC) Terror and medicine - the challenge
2003     Israel Center for Technology Assessment in Health Care (ICTAHC) Terror and Medicine (New book written by over 100 medical experts in Israel in the fields of medicine dealing with the preparations for and treatment of victims of terror attacks)
2022     Malaysian Health Technology Assessment (MaHTAS) Tertiary care virtual online consultation between doctor and patient
2013     NIHR Horizon Scanning Centre (NIHR HSC) Tertomotide for locally advanced or metastatic pancreatic cancer
2005     NIHR Horizon Scanning Centre (NIHR HSC) Tesaglitazar for type 2 diabetes and associated lipid abnormalities - horizon scanning review
2011     HAYES, Inc. testing
2014     NIHR Health Services and Delivery Research programme Testing accelerated experience-based co-design: a qualitative study of using a national archive of patient experience narrative interviews to promote rapid patient-centred service improvement
2007     Haute Autorite de sante (HAS) Testing and detection of a lupus anticoagulant
1993     Health Council of the Netherlands Gezondheidsraad (GR) Testing and prediction
2006     Agency for Healthcare Research and Quality (AHRQ) Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure
2012     Medical Services Advisory Committee (MSAC) Testing for BRAF mutation in patients with metastatic melanoma for access to (1c) vemurafenib
2018     Penn Medicine Center for Evidence-based Practice (CEP) Testing for clostridium difficile in oncology patients
2007     Agency for Healthcare Research and Quality (AHRQ) Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).
2013     Medical Services Advisory Committee (MSAC) Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib
2007     Haute Autorite de sante (HAS) Testing for FV Leiden and FII 20210G>A mutations
2007     Haute Autorite de sante (HAS) Testing for Heparin-Induced thrombocytopenia
2012     Medical Services Advisory Committee (MSAC) Testing for HER-2 status in advanced or metastatic breast cancer (stage IIIA-IV) to access lapatinib
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Testing for HER2 positive breast cancer: a cost-effectiveness analysis
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Testing for HER2 positive breast cancer. Challenge for improvement of current conditions and practice
2012     Medical Services Advisory Committee (MSAC) Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab
2012     Medical Services Advisory Committee (MSAC) Testing for HER2 status in gastric cancer for access to trastuzumab
2003     ECRI Testing for HER2/NEU status in breast cancer
2017     Adelaide Health Technology Assessment (AHTA) Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
2015     Adelaide Health Technology Assessment (AHTA) Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
2023     Ontario Health Testing for homologous recombination deficiency in patients diagnosed with ovarian cancer
2013     Medical Services Advisory Committee (MSAC) Testing for V600 status in patients with locally advanced or metastatic melanoma for access to appropriate therapies
2013     Agency for Healthcare Research and Quality (AHRQ) Testing of CYP2C19 variants and platelet reactivity for guiding antiplatelet treatment
2021     NIHR Health Technology Assessment programme Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation
2020     National Institute for Health and Care Excellence (NICE) Testing strategies for Lynch syndrome in people with endometrial cancer. NICE diagnostics guidance 42
2003     Finnish Office for Health Care Technology Assessment (Finohta) Testing the regional application of information technology (IT) in social welfare and health care (Satakunta Macropilot project)
2005     NIHR Health Technology Assessment programme Testing treatments on animals: relevance to humans
2014     Health Quality Ontario (HQO) Testing vitamin B12 levels in neuropathy, alopecia, dizziness, and fatigue: a rapid review
2013     HAYES, Inc. Testosterone for low sexual desire in nonsurgically postmenopausal women
2009     HAYES, Inc. Testosterone for low sexual desire in premenopausal women
2009     HAYES, Inc. Testosterone for low sexual desire in surgically postmenopausal women
2022     Penn Medicine Center for Evidence-based Practice (CEP) Testosterone reference ranges for gender diverse individuals
2002     The Swedish Council on Health Technology Assessment (SBU) Testosterone replacement in men with age-related hormone deficiency - early assessment briefs (ALERT)
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tests for early diagnosis of sepsis
2022     Norwegian Institute of Public Health (NIPH) Tests for the detection of NTRK gene fusions in patients with locally advanced or metastatic solid tumours
2017     National Institute for Health and Care Excellence (NICE) Tests in secondary care to identify people at high risk of ovarian cancer. NICE diagnostics guidance 31
2020     National Institute for Health and Care Excellence (NICE) Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test). NICE diagnostics guidance 39
2003     Health Council of the Netherlands Gezondheidsraad (GR) Tetanus prophylaxis in injuries
2006     Health Council of the Netherlands Gezondheidsraad (GR) Tetrachloroethane; Health-based recommended occupational exposure limit
2015     NIHR Horizon Scanning Centre (NIHR HSC) Texture analysis of Radiological images (TexRAD) for lung cancer assessment
2021     Institute for Clinical and Economic Review (ICER) Tezepelumab for severe asthma
2023     National Institute for Health and Care Excellence (NICE) Tezepelumab for treating severe asthma. NICE technology appraisal guidance 880
2014     NIHR Horizon Scanning Centre (NIHR HSC) TH-302 in combination with doxorubicin for locally advanced or metastatic, unresectable soft tissue sarcoma – first line
1999     ECRI Thalamic stimulation for Parkinson's disease
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Thalamic stimulation for tremor treatment (systematic review, primary research, expert panel)